To the Editor:
Converging lines of evidence from human studies and experimental models have recently suggested a putative pathogenetic role of mitochondrial biology in neuropsychiatric disorders including depression. However, mitochondrial regulation is tissue-specific and varies substantially between subsets of cell populations, particularly in the immune system, where mitochondrial bioenergetics and dynamics drive cell function. Thus, while the peripheral immune system is an attractive biomarker candidate due to its easy accessibility in humans and its likely involvement in mood disorders, investigations in this area will require detailed workup of cellular specificity and functional implications to gain insight into potentially druggable pathobiological substrates.
In this journal, Scaini et al. [1] reported altered expression of key mitochondrial proteins including Mfn-2, short Opa-1 and Fis-1 in peripheral blood mononuclear cells (PBMCs) from a cross-sectional cohort of MDD patients compared to healthy controls. Moreover, their analyses suggested that expression of some of these mitochondrial markers might be linked to low grade inflammation (as determined by CRP levels). While mitochondrial functions were not tested directly in this study, the differential expression of these proteins in PBMCs supports earlier reports of altered cellular respiration of PBMCs obtained from patients with MDD (e.g. [2]). Moreover, the study adds to converging evidence from a recent metabolomics study [3] and a genetic investigation using Mendelian randomization [4], which implicated mitochondrial biology in the pathogenesis of depression.
However, it is becoming increasingly clear that different cell types harbor unique mitochondrial phenotypes and functions. In the immune system, mitochondrial bioenergetics and dynamics are key drivers of immune cell differentiation and function [5] and—consequently—there are very large differences in the mitochondrial phenotypes among different cell lineages (e.g., monocytes, B and T lymphocytes) and activation or differentiation states (e.g., memory vs naïve) [6]. Mirroring differences on a functional and protein level (Fig. 1a), RNA expression levels of key mitochondrial genes reported to differ between MDD and controls also vary by up to 37-242% among immune cell subtypes, and—importantly—between these subtypes vs PBMCs (Fig. 1b) [7].
This point is relevant to depression, because numerous studies have shown that MDD is associated with shifts in immune subset composition (see Fig. 1c). As an example, the largest and most recent immunophenotyping study in MDD [8] showed a number of enumerative differences including higher circulating numbers of monocyte subsets and CD4+ T cells in MDD compared to controls. This immune signature was also linked to elevated serum markers such as CRP, characterizing a subgroup of “inflamed” depression. Moreover, the degree of alterations in mitochondria such as respiratory chain function appears to differ between cell populations of the adaptive and innate immune system when compared between patients with MDD and closely matched healthy controls [9] (see Fig. 1d). Here, group differences in mitochondrial respiration were much more pronounced in T cells compared to monocytes. Importantly, such lineage-specific differences within the immune system might be biologically relevant in depression as an elegant experimental study in mice [10] demonstrated that adoptive transfer of CD4+ T cells (but not CD8+ T cells) from stressed mice was sufficient to induce depression/anxiety-like behavior in (unstressed) recipient mice (see Fig. 1e). In a series of well-controlled experiments, the authors established that a defect in mitochondrial fusion specifically in CD4+ T cells was the key mechanism for this effect.
Thus, when examining cellular or molecular markers in bulk-PBMCs, shifts in the composition of the immune cell subsets within the PBMC sample could mask, blunt, or maybe even drive apparent group differences in case-control studies of MDD. Future studies should therefore consider the inherent cellular specificity and functional implications of immune cell mitochondria, which will help to separate what constitutes an epiphenomenon from robust bioenergetic features and potential therapeutic targets of MDD.
References
Scaini G, Mason BL, Diaz AP, Jha MK, Soares JC, Trivedi MH, et al. Dysregulation of mitochondrial dynamics, mitophagy and apoptosis in major depressive disorder: does inflammation play a role? Mol Psychiatry. 2021. https://doi.org/10.1038/s41380-021-01312-w.
Karabatsiakis A, Böck C, Salinas-Manrique J, Kolassa S, Calzia E, Dietrich DE, et al. Mitochondrial respiration in peripheral blood mononuclear cells correlates with depressive subsymptoms and severity of major depression. Transl Psychiatry. 2014;4:e397. https://doi.org/10.1038/tp.2014.44.
Zacharias HU, Hertel J, Johar H, Pietzner M, Lukaschek K, Atasoy S, et al. A metabolome-wide association study in the general population reveals decreased levels of serum laurylcarnitine in people with depression. Mol Psychiatry. 2021. https://doi.org/10.1038/s41380-021-01176-0.
Milaneschi Y, Arnold M, Kastenmüller G, Dehkordi SM, Krishnan RR, Dunlop BW, et al. Genomics-based identification of a potential causal role for acylcarnitine metabolism in depression. medRxiv. 2021. https://doi.org/10.1101/2021.10.18.21265157.
Buck MD, Sowell RT, Kaech SM, Pearce EL. Metabolic instruction of immunity. Cell. 2017;169:570–86. https://doi.org/10.1016/j.cell.2017.04.004.
Rausser S, Trumpff C, McGill MA, Junker A, Wang W, Ho S, et al. Mitochondrial phenotypes in purified human immune cell subtypes and cell mixtures. eLife. 2021;10:e70899. https://doi.org/10.7554/eLife.70899.
Uhlén M, Fargerberg L, Hallström BM, Lindskog C, Oksvold P, Mardinoglu A, et al. Tissue-based map of the human proteome. Science. 2015;347:1260419. https://doi.org/10.1126/science.1260419.
Lynall ME, Turner L, Bhatti J, Cavanagh J, de Boer P, Mondelli V, et al. Peripheral blood cell–stratified subgroups of inflamed depression. Biol Psychiatry. 2020;88:185–96. https://doi.org/10.1016/j.biopsych.2019.11.017.
Gamradt S, Hasselmann H, Taenzer A, Brasanac J, Stiglbauer V, Sattler A, et al. Impaired mitochondrial respiration in T cells of patients with major depressive disorder. iScience. 2021;24:103312. https://doi.org/10.1016/j.isci.2021.103312.
Fan KQ, Li YY, Wang HL, Mao XT, Guo JX, Wang F, et al. Stress-induced metabolic disorder in peripheral CD4+ T cells leads to anxiety-like behavior. Cell. 2019;179:864–79.E819. https://doi.org/10.1016/j.cell.2019.10.001.
Acknowledgements
This investigation was supported in part by a Mentor-Based Postdoctoral Fellowship Program in Rehabilitation Research [MB-1707-28359] from the National Multiple Sclerosis Society (to SMG). The funder of the work had no role in conception, data retrieving or interpretation, and writing. The authors had full access to all the data mentioned and final responsibility for the decision to submit for publication.
Funding
Open Access funding enabled and organized by Projekt DEAL.
Author information
Authors and Affiliations
Contributions
SMG conceptualized and drafted the paper. JB, SG, ASM, and SMG analyzed data. JB, SG, CO, YM, ASM, and MP revised the paper for important intellectual content.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Brasanac, J., Gamradt, S., Otte, C. et al. Cellular specificity of mitochondrial and immunometabolic features in major depression. Mol Psychiatry 27, 2370–2371 (2022). https://doi.org/10.1038/s41380-022-01473-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41380-022-01473-2
This article is cited by
-
Accelerated biological aging and risk of depression and anxiety: evidence from 424,299 UK Biobank participants
Nature Communications (2023)